Sight Sciences appoints Gerhard Burbach to Board; annual meeting elects directors and ratifies auditor

Sight Sciences, Inc.

Gerhard F. Burbach appointed to Board and Audit Committee (appointment previously disclosed April 21, 2025).
Annual meeting held June 5, 2025 with 75.1% of shares represented; three Class I directors elected.
Directors elected: Paul Badawi (24,675,076 for), Brenda Becker (20,923,888 for), Erica Rogers (23,914,492 for).
Ratification of Deloitte & Touche as independent auditor for FY2025 passed (38,080,605 for, 26,937 against, 706,687 abstain).
No other matters were presented or voted upon at the annual meeting.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gerhard F. Burbach

Director

SGHT · Sight Sciences, Inc.

Effective: 2025-04-21
Filed: June 5, 2025, 7:59 PM ET

As previously disclosed, on April 21, 2025, the Board of Directors (the “Board”) of Sight Sciences, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Gerhard F. Burbach to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gerhard F. Burbach was appointed as Director at Sight Sciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

As previously disclosed, on April 21, 2025, the Board of Directors (the “Board”) of Sight Sciences, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Gerhard F. Burbach to the Board.

View on SEC.gov

Sight Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-135930

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.